News

The National LGBTQ Task Force drafted and submitted comments to the FDA on the 2015 Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products. The FDA’s new guidance represented the most recent revision by the Food and Drug Administration (FDA) since 1992.

Criminalizing HIV in MO (2015)

Rebecca Rivas